Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?
Christine De BruynThaïs BaertThierry van den BoschAn CoosemansPublished in: Current oncology reports (2020)
Circulating biomarkers as a liquid biopsy could be beneficial as a diagnostic tool in uterine sarcomas. For both carcinomas and sarcomas, circulating biomarkers could be of use in predicting early disease recurrence. This review in endometrial carcinoma and uterine sarcoma focus on circulating biomarkers; such as proteins; circulating tumor cells; circulating tumor DNA; microRNA; and immune cells.